Tradestie Institutional Equity Comparison Engine

AYTU vs AIM โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AYTU Overall Edge

AYTU Captures Institutional Edge (2โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to AYTU BioPharma, Inc. Common Stock (AYTU) driven by superior Growth & Margin, Momentum & Technical while AIM counters with relative strength in Valuation. Fundamentally, AYTU trades at 9.2x Forward P/E with -14.4% operating margin (+6.4% YoY revenue) versus AIM at 2.0x Forward P/E and -11724.2% operating margin (+4.0% YoY). In options structure, AYTU sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against AIM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner AIM
AYTU 9.2x vs AIM 2.0x Fwd P/E
Growth & Margin Winner AYTU
Op Margin -14.4% vs -11724.2% ยท YoY +6.4% vs +4.0%
Momentum & Technical Winner AYTU
1Y -12.1% vs -90.9% ยท 52W Pos 5% vs 1%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
AYTU NASDAQ
AYTU BioPharma, Inc. Common Stock
Pharmaceutical Preparations
$1.81
+1.69% 1D
Market Cap $19.6M
1M Return -11.27%
1Y Return -12.14%
Forward P/E 9.2x
Unified AI Score
48.9 / 100 HOLD
Tech 49.0 Fund 53.0 Flow 50.0 Mom 64.0
AIM NYSE American
AIM ImmunoTech Inc.
Biological Products, (No Disgnostic Substances)
$0.13
-7.1% 1D
Market Cap $5.9M
1M Return -20.64%
1Y Return -90.89%
Forward P/E 2.0x
Unified AI Score
52.8 / 100 HOLD
Tech 54.0 Fund 57.0 Flow 50.0 Mom 68.9

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AYTU -12.14% AIM -90.89% Spread: +78.75 pp (AYTU Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period AYTU Revenue AIM Revenue AYTU Op. Margin AIM Op. Margin Margin Edge
FY2019 $10M $0M -230.1% -8887.9% AYTU
FY2020 $30M $0M -76.5% -9295.7% AYTU
FY2021 $70M $0M -89.7% -13954.1% AYTU
FY2022 $100M $0M -113.7% -14129.8% AYTU
FY2023 $110M $0M -15.9% -15800.0% AYTU
FY2024 $70M $0M -2.4% -11630.6% AYTU
FY2025 $70M $0M -11.8% -13254.5% AYTU
FY2026 $60M N/A -14.4% N/A AYTU

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AYTU (6) vs AIM (4)
Institutional Metric AYTU AIM Criterion Row Winner
Market Capitalization Scale $19.6M $5.9M Larger Scale AYTU
Trailing P/E Ratio Valuation 9.2x 2.0x Lower Multiple AIM
Forward P/E Ratio Valuation 9.2x 2.0x Lower Multiple AIM
Revenue Growth (YoY) Growth +6.4% +4.0% Higher Growth AYTU
Operating Margin (TTM) Profitability -14.4% -11724.2% Higher Margin AYTU
Net Profit Margin Profitability -24.8% 0.0% Higher Margin AIM
Return on Equity (ROE) Capital Efficiency -52.5% -2382.3% Higher ROE AYTU
52-Week Range Position Momentum 5% ($2โ€“$3) 1% ($0โ€“$2) Stronger Trend AYTU
Beta / 30D Volatility Risk Regime 0.65ฮฒ ยท 35% Vol 0.32ฮฒ ยท 69% Vol Lower Realized Risk AYTU
Unified Institutional Score Composite Signal 48.9 / 100 (HOLD) 52.8 / 100 (HOLD) Higher Composite AIM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AYTU vs AIM Buy Guide
AYTU UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AYTU Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AIM UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AIM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AYTU nor AIM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.